GlassScriptPhysician profile
Tomasz Andrzej Timek
NPI 1578593612
$2,381.57
in general payments reported to CMS, 2019-2025
9 companies · $94.04 in 2025
The $94.04 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2021: $38.90 · 2022: $1,639 · 2023: $52.92 · 2024: $452 · 2025: $94.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,617.36 | 2022-2023 | Valiant Captivia |
| Atricure, INC. | $282.73 | 2019-2025 | Synergy Ablation System |
| Abbott Laboratories | $178.98 | 2024 | |
| Edwards Lifesciences Corporation | $121.10 | 2019-2024 | |
| Baxter Healthcare | $100.41 | 2021-2025 | Perclot |
| Convatec INC. | $28.24 | 2024 | |
| Depuy Synthes Sales INC. | $21.88 | 2024 | Matrixrib |
| W. L. Gore & Associates, INC. | $16.00 | 2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic Vascular, INC. | $14.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomasz Timek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.